Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials ; volume:9 ; number:1 ; day:29 ; month:4 ; year:2009 ; pages:1-6 ; date:12.2009
BMC cancer ; 9, Heft 1 (29.4.2009), 1-6, 12.2009
- Urheber
-
Vardy, Janette
- Beteiligte Personen und Organisationen
-
Dadasovich, Ryan
Beale, Philip
Boyer, Michael
Clarke, Stephen J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-9-130
- URN
-
urn:nbn:de:1111-2016030351542
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vardy, Janette
- Dadasovich, Ryan
- Beale, Philip
- Boyer, Michael
- Clarke, Stephen J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chemotherapy for Advanced Non-Small Cell Lung Cancer: Quest for the Best Continues
Eligibility criteria in clinical trials in breast cancer: a cohort study
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
Role of imaging for eligibility and safety of a-NGF clinical trials
Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study
Analysis of eligibility criteria in Alzheimer’s and related dementias clinical trials
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
Chemotherapy For Advanced Oral Cancer
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
Chemotherapy for Advanced Non-Small Cell Lung Cancer: Quest for the Best Continues
Eligibility criteria in clinical trials in breast cancer: a cohort study
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
Role of imaging for eligibility and safety of a-NGF clinical trials
Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study
Analysis of eligibility criteria in Alzheimer’s and related dementias clinical trials
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
Chemotherapy For Advanced Oral Cancer
Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer
Chemotherapy for Advanced Non-Small Cell Lung Cancer: Quest for the Best Continues
Eligibility criteria in clinical trials in breast cancer: a cohort study
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
Role of imaging for eligibility and safety of a-NGF clinical trials
Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study
Analysis of eligibility criteria in Alzheimer’s and related dementias clinical trials
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data
Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients
Chemotherapy For Advanced Oral Cancer